Results 51 to 60 of about 7,425 (214)

A comprehensive cuproptosis score and associated gene signatures reveal prognostic and immunological features of idiopathic pulmonary fibrosis

open access: yesFrontiers in Immunology, 2023
BackgroundCuproptosis, the most recently identified and regulated cell death, depends on copper ions in vivo. Copper regulates the pathogenesis of Idiopathic pulmonary fibrosis (IPF), but the mechanism of action underlying cuproptosis in IPF remains ...
Chuanqing Jing   +6 more
doaj   +1 more source

Screening and validating genes associated with cuproptosis in systemic lupus erythematosus by expression profiling combined with machine learning [PDF]

open access: yes
Cell death has long been a focal point in life sciences research, and recently, scientists have discovered a novel form of cell death induced by copper, termed cuproptosis.
Cheng, Ruoying   +4 more
core   +2 more sources

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma [PDF]

open access: yes, 2023
Bladder Urothelial Carcinoma (BLCA) remains the most common urinary system tumor, and its prognosis is poor. Cuproptosis is a recently discovered novel cell death involved in the development of tumor cells.
Jing Dai   +3 more
core   +1 more source

Role of cuproptosis-related gene in lung adenocarcinoma

open access: yesFrontiers in Oncology, 2022
BackgroundsLung adenocarcinoma (LUAD) is the most common subtype of lung cancer, which is the leading cause of cancer death. Dysregulation of cell proliferation and death plays a crucial role in the development of LUAD.
Yuan Liu   +6 more
doaj   +1 more source

Mitochondria-Targeted Multifunctional Nanoparticles Combine Cuproptosis and Programmed Cell Death-1 Downregulation for Cancer Immunotherapy [PDF]

open access: yes
The combination of cuproptosis and immune checkpoint inhibition has shown promise in treating malignant tumors. However, it remains a challenge to deliver copper ions and immune checkpoint inhibitors efficiently and simultaneously to tumors.
Li, Youyou   +3 more
core   +1 more source

Beyond Catalytic Therapy: Copper‐Paeonol Nanozymes Disrupt Fascin‐Mediated Actin Bundling to Suppress Tumor Growth and Metastasis

open access: yesAdvanced Science, EarlyView.
Copper‐paeonol nanozymes target tumor‐specific reactive oxygen species generation and disrupt fascin‐mediated actin bundling, effectively suppressing tumor growth and metastatic colonization. Abstract Fascin, an actin‐bundling protein universally upregulated in metastatic tumors, drives tumor migration and invasion by promoting filopodia and ...
Peiying Zhang   +8 more
wiley   +1 more source

Cuproptosis‐related molecular patterns and gene (ATP7A) in hepatocellular carcinoma and their relationships with tumor immune microenvironment and clinical features

open access: yesCancer Reports, 2023
Background Cuproptosis has been studied in various aspects as a new form of cell death. Aims We hope to explore the molecular patterns and genes related to cuproptosis in evaluating and predicting the prognosis of hepatocellular carcinoma (HCC), as well ...
Shanbao Li   +9 more
doaj   +1 more source

A novel cuproptosis-related prognostic signature and potential value in HCC immunotherapy

open access: yesFrontiers in Molecular Biosciences, 2022
Background: Copper metabolism plays an important role in the tumor microenvironment, and cuproptosis is the last discovered programmed cell death process.
Xiang-Xu Wang   +8 more
doaj   +1 more source

Tumor cuproptosis and immune infiltration improve survival of patients with hepatocellular carcinoma with a high expression of ferredoxin 1 [PDF]

open access: yes, 2023
BackgroundCuproptosis is a novel cell death pathway dependent on cellular copper ions and ferredoxin 1 (FDX1). Hepatocellular carcinoma (HCC) is derived from healthy liver as a central organ for copper metabolism.
Heng Xu   +5 more
core   +1 more source

Immunogenic cuproptosis in cancer immunotherapy via an in situ cuproptosis-inducing system

open access: yesBiomaterials
Cell death-based therapies combined with immunotherapy have great potential in cancer therapy. To further explore and apply the combined therapies, the immunogenicity of different cell death modes in colorectal cancer (CRC) was evaluated by a cause-and-effect framework encompassing 12 cell death modes. Results show robust correlations among cuproptosis,
Jiehan Li   +11 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy